ATTITUDE TO HEALTH;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER THERAPY;
CLINICAL DECISION MAKING;
COLORECTAL CANCER;
DRUG COST;
DRUG MISUSE;
DRUG USE;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HEALTH SURVEY;
HOSPITAL MANAGEMENT;
HUMAN;
LUNG NON SMALL CELL CANCER;
MEDICATION THERAPY MANAGEMENT;
MELANOMA;
NURSE;
ONCOLOGIST;
OUTPATIENT CARE;
PHARMACIST;
PROSTATE CANCER;
REVIEW;
ANTINEOPLASTIC AGENTS;
DATA COLLECTION;
DRUG COSTS;
DRUG UTILIZATION;
HUMANS;
NEOPLASMS;
ONCOLOGY SERVICE, HOSPITAL;
OUTPATIENT CLINICS, HOSPITAL;
OUTPATIENTS;
PATIENT CARE TEAM;
PHARMACY SERVICE, HOSPITAL;
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment
Jacobson M, Earle CC, Price M, et al: How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) 29: 1391-1399, 2010
Association between the medicare modernization act of 2003 and patient wait times and travel distance for chemotherapy
DOI 10.1001/jama.300.2.189
Shea AM, Curtis LH, Hammill BG, et al: Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA 300: 189-196, 2008 (Pubitemid 351969303)
Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the US medicare population
DOI 10.1002/cncr.23421
Weight CJ, Klein EA, Jones JS: Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. Cancer 112: 2195-2201, 2008 (Pubitemid 351628629)
Agency for Healthcare Research and Quality: Hospital survey on patient safety culture: 2012 user comparative database report. http://www.ahrq.gov/ qual/hospsurvey12/index.html